This is a newly started area, which is currently focused on the development of its own biodegradable polymers (based on polyglutamic acid) for drug delivery. The study of nanomedicines of polymeric nature is more easily affordable from the view of chemical synthesis and has a promising potential, not just for the delivery of conventional drugs, but also for genomic therapies (iRNA). It is also worth mentioning that these polymers are completely biodegradable and have been proved to be non-toxical in in vivo approaches.

On the other hand, this area also collaborates with external groups for the design and validation of nanoparticles of alternative natures, such as dendrimers, liposomes, silica nanoparticles, carbon nanotubes or magnetic nanoparticles.